Cardiac Monitoring Finds Arrhythmias, but Treatment Did Not Improve Outcomes
(MedPage Today) -- WASHINGTON -- While monitoring for arrhythmias in high-risk patients following myocardial infarction (MI) commonly detected rhythm events requiring treatment within 2 years, treatment did not lead to better outcomes, according... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - April 5, 2022 Category: Radiology Source Type: news
A Case of Dropped Beats: Management of a Common Fetal Arrhythmia
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - April 1, 2022 Category: Pediatrics Source Type: news
Magnets in Portable Electronic Devices May Interfere With CIEDs
TUESDAY, March 1, 2022 -- Magnets in portable electronic devices (PEDs) may interfere with cardiovascular implantable devices (CIEDs), according to a research letter published online March 1 in Circulation: Arrhythmia and Electrophysiology.
Noting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 1, 2022 Category: Pharmaceuticals Source Type: news
Mayo Clinic Minute: How myocarditis affects men, athletes
Myocarditis, an inflammation of the heart, is usually caused by a virus. It can reduce the heart's ability to pump, causing rapid or abnormal heart rhythms, or arrhythmias. In many cases, myocarditis improves on its own or with treatment. But health care providers often advise athletes to steer clear from activity for several months. Watch the Mayo Clinic Minute. https://www.youtube.com/watch?v=FVEkFLa5xwo Journalists: Broadcast-quality video natural sound pkg (1:00) is in the downloads at the end of… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 10, 2022 Category: Databases & Libraries Source Type: news
GZF and Ventricular Arrhythmias in Patients With a LVEF > 35% GZF and Ventricular Arrhythmias in Patients With a LVEF > 35%
This analysis explores whether myocardial fibrosis and greyzone fibrosis are associated with arrhythmic events in patients with coronary artery disease and an LVEF>35%.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2022 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Is Sinus Arrhythmia Serious?
Title: Is Sinus Arrhythmia Serious?Category: Diseases and ConditionsCreated: 2/2/2022 12:00:00 AMLast Editorial Review: 2/2/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 2, 2022 Category: Cardiology Source Type: news
No Evidence of Malignant, Sustained Arrhythmias Seen After COVID-19
TUESDAY, Jan. 25, 2022 -- For outpatients after a positive COVID-19 diagnosis, there is no evidence of malignant or sustained arrhythmias, according to a study published online Jan. 20 in Open Heart.
Thomas A. Dewland, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2022 Category: Pharmaceuticals Source Type: news
Total Alcohol Intake Not Linked to Ventricular Arrhythmia Risk
TUESDAY, Dec. 28, 2021 -- Total alcohol consumption is not associated with an increased risk for incident ventricular arrhythmia (VA), while there is a U-shaped association for alcohol consumption with the risk for sudden cardiac death (SCD),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2021 Category: Pharmaceuticals Source Type: news
Autonomic Modulation and Cardiac Arrhythmias Autonomic Modulation and Cardiac Arrhythmias
This review explores the complex contributions of the autonomic nervous system in cardiac disease, highlighting pharmacological and experimental autonomic modulation in treatment of arrhythmias.Europace (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 21, 2021 Category: Surgery Tags: Cardiology Journal Article Source Type: news
New Data from Phase 3 GLOW Study Show Fixed-Duration Treatment with IMBRUVICA ® (ibrutinib) Plus Venetoclax Demonstrated Deeper and Sustained Undetectable Minimal Residual Disease Outcomes in First-Line Chronic Lymphocytic Leukemia
ATLANTA, Ga., December 11, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from two studies evaluating the efficacy and safety of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) as a potential fixed-duration treatment in adult patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). These data were both featured today during the American Society of Hematology (ASH) 2021 Annual Meeting. New secondary endpoint data from the Phase 3 GLOW study (NCT03462719) showed that fixed-duration treatment with I+V resulted in undetectable min...
Source: Johnson and Johnson - December 11, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Booze Out, Coffee Okay to Outsmart AF? Booze Out, Coffee Okay to Outsmart AF?
Jagmeet Singh interviews Gregory Marcus about his n-of-1 study in which people with paroxysmal AF self-tested potential triggers, and the CRAVE study on coffee ' s effects on sleep, activity, and arrhythmias.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 9, 2021 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Mayo Clinic Minute: Watch for these heart arrhythmia red flags
A heart arrhythmia is an irregular heartbeat. It occurs when the electrical signals that tell the heart when to beat and pump blood aren't functioning properly. Some heart arrhythmias can be harmless and just bothersome, while others can be life-threatening. In this Mayo Clinic Minute, learn more about the red flags to watch out for. Watch: The Mayo Clinic Minute https://youtu.be/GJybmnXcqQE Journalists: Broadcast-quality video (1:10) is in the downloads at the end of this post.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 7, 2021 Category: Databases & Libraries Source Type: news
SGLT2 Inhibitor Use Tied to Fewer Atrial Arrhythmias SGLT2 Inhibitor Use Tied to Fewer Atrial Arrhythmias
Patients with cardiac implantable electronic devices who were treated with an SGLT2 inhibitor had significantly fewer atrial arrhythmias vs those never receiving them, new observational data suggest.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 2, 2021 Category: Primary Care Tags: Cardiology News Source Type: news
AI in the Diagnosis and Management of Arrhythmias AI in the Diagnosis and Management of Arrhythmias
This comprehensive state-of-the-art overview discusses the impact of artificial intelligence on all aspects of arrhythmia care, from detection to therapeutic management.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Atrial fibrillation: The everyday food item ‘significantly’ increasing your risk
ATRIAL FIBRILLATION - or heart arrhythmia - is dangerous because it boosts the risk of blood clots, which in turn can lead to stroke. There are myriad foods to avoid in order to curtail the risk of heart complications - but one everyday food item is often overlooked as a culprit. (Source: Daily Express - Health)
Source: Daily Express - Health - November 16, 2021 Category: Consumer Health News Source Type: news
